Francis Dubé



dynaCERT Inc.
Latest Comments
image_pdfimage_print

Dr Dube and Greg Fenton on ZEN’s potential graphene-based antibiotic, antiviral and antifungal compound

In a recent InvestorIntel interview, Peter Clausi speaks with Dr. Francis Dube, Executive Chairman, and Greg Fenton, CEO and Director […]


Dr. Dube on competitive graphene technology and the recent testing partnership between ZEN, the Royal Canadian Navy and Evercloak

In a recent interview with InvestorIntel, Tracy Weslosky speaks with Dr. Francis Dube, CEO and Director of ZEN Graphene Solutions […]


Dr. Francis Dube on the advancement of mask technologies and ZEN’s graphene based virucidal ink with 99% efficacy

InvestorIntel’s Tracy Weslosky speaks with Dr. Francis Dube, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: ZEN), about ZEN’s […]


Lab tests show ZEN Graphene’s virucidal ink 99% effective against COVID-19; patent applied for

Optimization, production scale-up and commercialization planned Another month deeper into the global COVID-19 crisis and the world is still looking […]


ZEN Graphene Solutions moves towards commercialization of virus-killing mask

ZEN is collaborating with partners to develop virucidal face masks and PPE Back in May 2020 InvestorIntel wrote about the […]


Scaling up graphene production to meet forecast demand, ZEN Graphene shares double since April

In recent years we have heard that graphene can be the next super material due to its immense strength and […]


A graphene based virucidal ink face mask and line of clothing that does more than protect — it intends to kill COVID-19

The face mask sector is hot right now. Even China can’t make enough face masks to meet their own demand. […]